88 related articles for article (PubMed ID: 32253932)
1. Linkage disequilibrium and haplotype analysis of
Nisar A; Mahjabeen I; Mehmood A; Ahmed MW; Khurshid K; Kayani MA
Future Oncol; 2020 Apr; 16(12):779-792. PubMed ID: 32253932
[No Abstract] [Full Text] [Related]
2. Fyn and Lyn gene polymorphisms impact the risk of thyroid cancer.
Nisar A; Kayani MA; Nasir W; Mehmood A; Ahmed MW; Parvez A; Mahjabeen I
Mol Genet Genomics; 2022 Nov; 297(6):1649-1659. PubMed ID: 36058999
[TBL] [Abstract][Full Text] [Related]
3. Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer.
Sarwar R; Mahjabeen I; Bashir K; Saeed S; Kayani MA
Cell Physiol Biochem; 2017; 42(1):22-33. PubMed ID: 28490032
[TBL] [Abstract][Full Text] [Related]
4. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
Lesueur F; Corbex M; McKay JD; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar DE; Romeo G
J Med Genet; 2002 Apr; 39(4):260-5. PubMed ID: 11950855
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
Song CM; Kwon TK; Park BL; Ji YB; Tae K
Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
[TBL] [Abstract][Full Text] [Related]
6. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
7. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
[TBL] [Abstract][Full Text] [Related]
8. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
[TBL] [Abstract][Full Text] [Related]
10. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
13. A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression.
Ju H; Lim B; Kim M; Kim YS; Kim WH; Ihm C; Noh SM; Han DS; Yu HJ; Choi BY; Kang C
Neoplasia; 2009 Dec; 11(12):1340-7. PubMed ID: 20019842
[TBL] [Abstract][Full Text] [Related]
14. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
15. YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
Garmendia I; Pajares MJ; Hermida-Prado F; Ajona D; Bértolo C; Sainz C; Lavín A; Remírez AB; Valencia K; Moreno H; Ferrer I; Behrens C; Cuadrado M; Paz-Ares L; Bustelo XR; Gil-Bazo I; Alameda D; Lecanda F; Calvo A; Felip E; Sánchez-Céspedes M; Wistuba II; Granda-Diaz R; Rodrigo JP; García-Pedrero JM; Pio R; Montuenga LM; Agorreta J
Am J Respir Crit Care Med; 2019 Oct; 200(7):888-899. PubMed ID: 31166114
[No Abstract] [Full Text] [Related]
16. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer.
Liu L; Yang J; Zhu X; Li D; Lv Z; Zhang X
FEBS J; 2016 Jun; 283(12):2326-39. PubMed ID: 27093644
[TBL] [Abstract][Full Text] [Related]
18. Impact of CD40 gene polymorphisms on the risk of immune thrombocytopenic purpura.
AbdelGhafar MT; El-Kholy RA; Elbedewy TA; Allam AA; Eissa RAE; Samy SM; El-Khalik SRA; Rabah H
Gene; 2020 Apr; 736():144419. PubMed ID: 32018016
[TBL] [Abstract][Full Text] [Related]
19. The potential role of the sodium iodide symporter gene polymorphism in the development of differentiated thyroid cancer.
Al-Rasheed MM; Alzahrani AS; Macadam A; Overall A; Gard P; Dzimiri N
Gene; 2015 Nov; 572(2):163-8. PubMed ID: 26160439
[TBL] [Abstract][Full Text] [Related]
20. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.
Borrego S; Wright FA; Fernández RM; Williams N; López-Alonso M; Davuluri R; Antiñolo G; Eng C
Am J Hum Genet; 2003 Jan; 72(1):88-100. PubMed ID: 12474140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
